davgro’s details
| symbol | subject | date & time | rating |
|
|
Was there any time restrictions placed on the sale of shares from the recent public offering ? If not, is it not possible that the recent downtrend in the share price could be a result of recently acquired shares from the public offering being ... |
5/8/2013 3:13:13 PM |
|
|
|
Belo Sun Mining (TSX:BSX) dropped by as much as 37% on Tuesday as investors reacted negatively to a pre-feasibility study for its Volta Grande gold project in central Brazil. By midmorning the Toronto-based company had recovered somewhat to cha... |
5/7/2013 12:32:44 PM |
5 |
|
|
Trimel Pharmaceuticals Announces Closing of Overallotment Option36 minutes ago by Marketwire Canada - NFD NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Trimel Pharmaceuticals Corporation (TSX:TRL) is ple... |
5/1/2013 8:57:09 AM |
|
|
|
Canaccord Genuity cuts target price to $19.75 from $20.75 citing the company's weak first-quarter results. http://www.reuters.com/article/2013/05/01/markets-canada-stocks-idUSL3N0DI1VA20130501 |
5/1/2013 8:53:25 AM |
|
|
|
The board lot data showing in TD Waterhouse's WebBroker is erroneous and has been since pre-market yesterday. I have been on the phone with multiple contacts at TD Waterhouse over the past 36-hours discussing this matter. I have been told t... |
4/30/2013 7:08:43 PM |
4 |
|
|
The board lot data showing in TD Waterhouse's WebBroker is erroneous and has been since pre-market yesterday. I have been on the phone with multiple contacts at TD Waterhouse over the past 36-hours discussing this matter. I have been told ... |
4/30/2013 7:01:10 PM |
4 |
|
|
Yamana Gold missed analyst consensus expectations on both revenue and net profit. it will be interesting to see if the market punishes the stock tomorrow for the misses. The analyst consensus was for a net profit of 0.19 per share (actual adjust... |
4/30/2013 6:45:59 PM |
|
|
|
Trimel Pharma : RBC cuts price target to C$2.50 from C$6; rating outperform https://research.tdwaterhouse.ca/research/public/Stocks/NewsArticle/ca/TRL?documentKey=1314-L3N0DG1RT-1 |
4/29/2013 3:33:04 PM |
|
|
|
Should we anticipate an opening price on the resume of trading that is below the 0.80 share offering price ? And if so, how low do you think it will it go ? Just looking for some insights / opinion from other posters. Thanks |
4/18/2013 12:05:45 PM |
4 |
|
|
Trimel Pharmaceuticals arranges $40-million financing2013-04-18 11:56 ET - News Release Mr. Kenneth Howling reports TRIMEL PHARMACEUTICALS CORPORATION ANNOUNCES TERMS OF $40 MILLION EQUITY FINANCING In connection with its previously announc... |
4/18/2013 11:58:51 AM |
|
|
No additional content to display.
Stockhouse.com: Taking
it to the street
